FDA Hones In On Critical Issues With Recruitment, Inclusion of Women in Clinical Trials

The US Food and Drug Administration (FDA) is looking to break down barriers hindering the availability of clinical trial data on women by focusing on two critical issues—enrollment and new products designed for treating conditions that are gender-unique.